Cost impact model of a novel multi-mRNA host response assay for diagnosis and risk assessment of acute infections and sepsis in the ED

2021-07-09T11:11:02-07:00

Schneider JE, Romanowsky J, et al. JHEOR. 2020.

Go to Top